Billy Gregory
Associate
Billy is an associate in our corporate finance team, specialising in private M&A and investments, corporate re-organisations, equity funding, IPOs and capital markets, and general corporate advisory matters.
Associate
Billy is an associate in our corporate finance team, specialising in private M&A and investments, corporate re-organisations, equity funding, IPOs and capital markets, and general corporate advisory matters.
Language - English
Jurisdiction - England & Wales
Billy advises clients across a range of corporate transactions including share and asset acquisitions and disposals, joint ventures, group reorganisations, venture capital, equity funding and private equity transactions. He also has further experience with IPOs and capital markets.
Billy’s experience includes working with UK-based and international clients across a broad range of industries.
Oaktree Capital Management – Sale of Fleetscape Financing Transactions to Quantum Pacific
Advised funds managed by Oaktree Capital Management on the sale of financing transactions by Fleetscape, a leading alternative capital provider to the maritime industry, to Quantum Pacific.
Vulcan Two Group plc – AIM IPO and Fundraising
Advised Vulcan Two Group plc on its AIM IPO and fundraising, raising £12 million through an institutional placing and subscription.
Dr. Falk Pharma GmbH – Acquisition of Kynos Therapeutics Ltd
Advised Dr. Falk Pharma GmbH on its acquisition of Kynos Therapeutics Ltd, a clinical stage biopharmaceutical company focused on novel treatments for inflammatory diseases.
The MECO Group Limited – Sale to Markel International
Advised the shareholders of The MECO Group Limited, a specialist marine MGA, on its sale to Markel International.
